metastatic cancer trang 6 tải miễn phí từ TAILIEUCHUNG

"metastatic cancer" trang 6 - tải miễn phí từ Tailieuchung

Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer

Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer

5 68 1

The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice

The effects of 1,4-dimethylpyridine in metastatic prostate cancer in mice

12 41 1

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

10 39 1

Efficacy and safety profile of nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic cancer treated to disease progression: A subanalysis from a phase 3 trial (MPACT)

10 51 1

RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: Results from a Europewide survey of pathology centres

RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: Results from a Europewide survey of pathology centres

11 44 1

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients

8 49 1

A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer

A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancer

8 52 1

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

10 43 1

The treatment patterns, efficacy, and safety of nab® -paclitaxel for the treatment of metastatic breast cancer in the United States: Results from health insurance claims analysis

The treatment patterns, efficacy, and safety of nab® -paclitaxel for the treatment of metastatic breast cancer in the United States: Results from health insurance claims analysis

11 58 1

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: A retrospective study

Eribulin-induced liver dysfunction as a prognostic indicator of survival of metastatic breast cancer patients: A retrospective study

9 33 1

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

9 32 1

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

A single-arm phase II trial of combined chemotherapy with S-1, oral leucovorin, and bevacizumab in heavily pre-treated patients with metastatic colorectal cancer

8 31 1

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: A retrospective study in 107 patients

The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: A retrospective study in 107 patients

7 21 1

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: The phase II AVAXIRI study

Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: The phase II AVAXIRI study

9 20 1

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use programme in France

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use programme in France

9 19 1

DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

DEK is a potential marker for aggressive phenotype and irinotecan-based therapy response in metastatic colorectal cancer

10 35 1

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors

Outcomes after stereotactic body radiotherapy for lung tumors, with emphasis on comparison of primary lung cancer and metastatic lung tumors

10 37 1

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: A prospective study in 393 patients

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: A prospective study in 393 patients

12 29 1

A VELOUR post hoc subset analysis: Prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI

A VELOUR post hoc subset analysis: Prognostic groups and treatment outcomes in patients with metastatic colorectal cancer treated with aflibercept and FOLFIRI

9 27 1

Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results

Bevacizumab in first-line treatment of elderly patients with metastatic colorectal cancer: German community-based observational cohort study results

10 33 1

Đầu
1
2
3
4
5
[ 6 ]
7
8
9
10
11
12
13
14
15
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.